Wilson Sonsini Goodrich & Rosati is representing LENZ Therapeutics in the transaction, Goodwin Procter is representing Graphite Bio and Latham & Watkins is representing the placements...
LENZ Therapeutics’ Merger with Graphite Bio
Biotheus’ Partnership with BioNTech
Goodwin Procter advised Biotheus Inc. on the agreement with BioNTech. Biotheus Inc. announced an exclusive global license and collaboration agreement with BioNTech. BioNTech will be developing, manufacturing...
Amphastar Pharmaceuticals’ $345 Million Convertible Senior Notes Offering
Goodwin advised the initial purchasers on Amphastar Pharmaceuticals, Inc.’s offering. Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced the Rule 144A offering of 2.00% Convertible Senior Notes due...
TowerBrook’s Acquisition of Majority Stake in Team Eiffel
Loyens & Loeff N.V. and Goodwin advised TowerBrook Capital Partners on the acquisition of Team EIFFEL B.V.. TowerBrook Capital Partners has acquired a majority stake in Team...
Intrum’s Acquisition of Ophelos
Goodwin Procter advised Ophelos on its sale to Intrum. Through the sale, Ophelos will be able to scale and accelerate their AI products by tapping into...
Ai Build’s $8.5 Million Series A Funding
Goodwin Procter advised Ai Build on the funding round. Ai Build, a London, UK-based additive manufacturing software company, raised $8.5M in Series A funding. The round...
IBM’s Acquisition of Manta Software
Goodwin Procter advised Manta Software in its acquisition by IBM. IBM acquired Manta Software Inc – a world-class data lineage platform — to complement its capabilities within...
TitanML’s £2.3 Million Pre-Seed Round
Goodwin advised Octopus Ventures on their lead investment into TitanML. AI company, TitanML, has secured $2.8M in pre-seed funding led by Octopus Ventures alongside deep tech-focused...
In re GE ERISA Litigation
Robbins Geller Rudman & Dowd LLP, Block & Leviton and Gardy & Notis reached a $61 million settlement, pending final approval, in a case against General...
Kingswood Capital Management’s Acquisition of Covenant Testing Technologies
Goodwin Procter LLP and Grant Thornton advised Kingswood on the investment. Kingswood Capital Management, LP has acquired Covenant Testing Technologies, a well-flow management and equipment rental...
Breathe Battery’s $10 Million Series A Financing Round
Goodwin advised Lowercarbon Capital on the investment in Breathe Battery. Breathe Battery Technologies Limited secured a $10 million Series A funding round, led by Lowercarbon Capital...
Advanced Biologics’ Merger with Isto Biologics
Goodwin Procter advised Advanced Biologics in its merger with Isto Biologics. Isto Biologics, a portfolio company of TSCP and a global leader in regenerative and autologous...